🟢 Heron Therapeutics is trading 5.9% up today with no identified company-specific catalyst

Heron Therapeutics is trading $0.34, up 5.90%, with no new company-specific announcement identified for August 12, 2026.

• The August 10 earnings miss, withdrawn 2026 guidance, CINVANTI patent uncertainty, and strategic-alternatives review remain the latest major catalysts, but do not clearly explain today’s positive move.
• Broader markets are modestly higher after benign CPI data, while the Nasdaq is up 0.47%, below the specified threshold.